Pvg Asset Management Corp Cardiol Therapeutics Inc. Transaction History
Pvg Asset Management Corp
- $21.3 Million
- Q1 2025
A detailed history of Pvg Asset Management Corp transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Pvg Asset Management Corp holds 437,362 shares of CRDL stock, worth $559,823. This represents 1.99% of its overall portfolio holdings.
Number of Shares
437,362
Previous 487,295
10.25%
Holding current value
$559,823
Previous $628,000
32.48%
% of portfolio
1.99%
Previous 3.54%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
44Shares Held
7.41MCall Options Held
25.9KPut Options Held
1.7K-
Tejara Capital LTD London, X03.19MShares$4.09 Million1.2% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$1.1 Million0.22% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9783KShares$1 Million0.35% of portfolio
-
Ubs Group Ag498KShares$637,2560.0% of portfolio
-
Lion Street Advisors, LLC340KShares$435,2320.15% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $79.3M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...